At the 2026 American Academy of Neurology Annual Meeting in Chicago, IL, investigators presented real-world evidence evaluating whether glucagon-like peptide-1 receptor agonists influence healthcare...
Clinicians assessing health-related quality of life in children with epilepsy now have clearer benchmarks. A new study provides the first estimates of the minimum clinically important difference for the...
A diverse team of experts representing the National Association of Epilepsy Centers updated a set of guidelines and recommendations for the care of patients with epilepsy.
This COVID-19 roundup includes coverage of the FDA’s modification of bivalent vaccines in infants aged 6 months, the NIH advises against the use of bebtelovimab, and impact COVID-19 has on short-term...
Women with epilepsy frequently need medication to prevent seizures during pregnancy and the risk of prenatal exposure of children is important to understand. Researchers examined the impact of prenatal...
The FDA has approved a drug therapy to treat seizures associated with Dravet syndrome–a chronic, rare, and life-threatening form of epilepsy–among patients aged 2 years or older.
The Epilepsy Bioinformatics Study for Antiepileptogenic Therapy project aims to better understand epilepsy and, therefore, to develop epilepsy-preventive therapies. Project Director of EpiBioS4Rx Jerome...
This approval comes after the drug was found to be safe and effective in 2 randomized, double-blind, placebo-controlled trials including 655 adults with partial-onset seizures.
